FCE PHARMA was first organized in 1995 and has been successfully held for 26 times so far. The exhibition is designed to be the largest pharmaceutical industry exhibition in South America, providing a professional communication platform for international and local enterprises to fully meet the needs of domestic buyers and facilitate the display of foreign exhibitors.
2023 Xi'an Paid Travel for Outstanding Employees
The 9th International Exhibition of Pharmaceuticals, Engineering and Biotechnology (International Exhibition of Pharmaceuticals, Engineering and Biotechnology) will continue to be held in St. Petersburg, Russia on April 2-4, 2024, the last exhibition attracted 112 exhibitors from 19 countries and regions, of which the number of professional visitors reached more than 3,500, of which the local Russian audience accounted for about 85%. The last exhibition attracted 112 exhibitors from 19 countries and regions, and the number of professional visitors reached more than 3,500, of which the local visitors in Russia accounted for about 85%, and the other visitors mainly came from Europe, India, South Korea and other countries and regions.
Fueling Scientific Advancement: Fostering Innovation and Competitiveness in the Pharmaceutical Sector
Time goes by, years change, in a blink of an eye, the busy year has passed. With passion and challenge, a new year is coming. On the occasion of the New Year's Day, Chenghui Shuangda's 2018 recognition conference was held on January 28 at the Ni's Haitai Hotel in Jinan. The conference invited many partners and Chenghui Shuangda employees to gathering together.
The General Office of the State Council recently issued the Guiding Opinions on Further Deepening the Reform of the Payment Method for Basic Medical Insurance(hereinafter referred to as the Opinions), proposing to further strengthen the budget management of the medical insurance fund from 2017 onwards. The multivariate compound payment method based on disease payment is fully implemented. Experts believe that the medical insurance payment system reform will become the key mechanism of medical service cost control under the premise that the medical insurance market has been formed in our country and medical insurance payment has become the main source of compensation for public hospitals.
Xi Jinping, General Secretary of the CPC Central Committee, President of the State Council, Chairman of the Central Military Commission and Chairman of the Central Committee's Comprehensive Reform Leading Group, presided over the 37th meeting of the Central Committee's Comprehensive Reform Leading Group on the afternoon of July 19 and delivered an important speech.
The company has a complete quality assurance system and strong scientific research and innovation capabilities. Every year, new synthetic drugs that are market-oriented and have a high technical content are launched. We are willing to provide you with high quality products and competitive price.